Matthew Byington, DO
Orthopaedic Surgery · Lincoln, NENPI 1275725905
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.2%), education and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 42.6% of the total. Reporting peaked in 2019 at $4,202 and has fallen 93.5% since, to $273 in 2025.
Across 78 payments — averaging $134.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Conetic Solutions, Inc.$2K
- Johnson & Johnson$1K
- Stryker$1K
- Vericel Corporation$1K
- Smith+Nephew$257
- plus $193 from 6 others
What the payments were for
- Travel & lodging$4,95247%
- Food & beverage$2,17321%
- Education$3,36832%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 25 | $4,470 |
| Conetic Solutions, Inc. | 8 | $1,991 |
| Johnson & Johnson | 13 | $1,272 |
| Stryker | 13 | $1,257 |
| Vericel Corporation | 8 | $1,052 |
| Smith+Nephew | 3 | $257 |
| Medical Device Business Services, Inc. | 3 | $94 |
| Misonix Inc | 1 | $31 |
| FX Shoulder Solutions, Inc | 1 | $25 |
| RSW Medical Company, Inc. | 1 | $18 |
| Amgen | 1 | $12 |
| Zimmer Biomet | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$989
- MAKO$919
- MACI$809
- T-Fix$170
- Journey II BCS$170
- PICO 7 Single Use Negative Pressure Wound Therapy$170
- REDAPT Revision Hip System$170
How this compares
$10,493 in reported general payments places this provider in the 75th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 48 | $788 |
| Meloxicam | 208 | $575 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $208 |
| Oxycodone Hcl | 25 | $207 |
| Methylprednisolone | 26 | $149 |
| Tramadol Hcl | 22 | $132 |
| Cyclobenzaprine Hcl | 12 | $64 |
| Clindamycin Hcl | 24 | $22 |
| Amoxicillin | 14 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lincoln
- Benjamin WoodheadLincoln$48K
- Matthew FreemanLincoln$30K
- Lukas HashemLincoln$25K
- David SamaniLincoln$22K
- Nickolas van RoekelLincoln$9K
- Dane ToddLincoln$9K
- Steven WahlmeierLincoln$9K
- Brandon SeifertLincoln$7K
- Todd SekundiakElkhorn$7.3M
- Heber CrockettKearney$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.